Nettoinventarwert (NAV)
| 9.17 EUR | 0.21 EUR | 2.34 % |
|---|
| Vortag | 8.96 EUR | Datum | 20.10.2026 |
Franklin Genomic Advancements Fund A (acc) EUR-H1 Fonds Kurs - 1 Jahr
Fundamentaldaten
| Valor | 116503668 |
| ISIN | LU2441052540 |
| Name | Franklin Genomic Advancements Fund A (acc) EUR-H1 Fonds |
| Fondsgesellschaft | Franklin Templeton International Services |
| Aufgelegt in | Luxembourg |
| Auflagedatum | 08.02.2022 |
| Kategorie | Branchen: Andere Sektoren |
| Währung | EUR |
| Volumen | 5’166’559.09 |
| Depotbank | J.P. Morgan SE, Luxembourg Branch |
| Zahlstelle | BNP Paribas Securities Services,Paris,succursale de Zurich |
| Fondsmanager | Matthew J. Moberg |
| Geschäftsjahresende | 30.06. |
| Berichtsstand | 23.10.2026 |
Anlagepolitik
So investiert der Franklin Genomic Advancements Fund A (acc) EUR-H1 Fonds: The Fund's investment objective is capital appreciation. The Fund invests principally in equity securities of companies that are relevant to the Fund’s investment theme of genomic advancements. Equity securities generally entitle the holder to participate in a company's general operating results. While the Fund invests predominantly in common stocks, it could also invest in preferred stock, convertible securities and warrants on securities.